R&D

In this report by It’s Not Healthy, we analyze the main vaccines that exist globally, their origin, their financing, aspects related to intellectual property, purchase agreements and their different prices. We show how the origin of vaccines is in projects developed for decades with large contributions of public money and that this knowledge and investment, together with the one made in the pandemic, have been left in the hands of the industry without conditions and without ensuring universal access or fair prices for all countries. In addition, we reveal that production is mainly concentrated in rich countries, while factories in Asia, Latin America and Africa are being wasted, despite the production and distribution problems that the pharmaceutical industry has shown.

01/06/2021

The vaccine: a global public good to face a pandemic

In this report by It’s Not Healthy, we analyze the main vaccines that exist globally, their origin, their financing, aspects related to intellectual property, purchase agreements and their different prices. We show […]
19/06/2020

Clinical research in Spain: a profile of clinical trials through their registry.

This report, carried out by Salud por Derecho, analyzes the data from the Spanish Registry of Clinical Studies —from 2013 to 2019— and reveals that viral diseases, such as COVID-19, were among […]
10/04/2020

Public investment in R&D in COVID-19

Informe de Salud por Derecho analyzes public investment in research and development of drugs and vaccines during the first months of the COVID-19 pandemic. Likewise, it includes a series of recommendations to […]
10/05/2018

Cancer drugs: high prices and inequality

The report prepared by No es Sano confirms that cancer treatments are one of the groups of drugs with the highest prices and that generate the most income for the pharmaceutical industry. […]